Submit a comment

Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.
H H Lemmink, W N Nillesen, T Mochizuki, C H Schröder, H G Brunner, B A van Oost, L A Monnens, H J Smeets
H H Lemmink, W N Nillesen, T Mochizuki, C H Schröder, H G Brunner, B A van Oost, L A Monnens, H J Smeets
View: Text | PDF
Research Article

Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.

Abstract

Benign familial hematuria (BFH) is characterized by autosomal dominant inheritance, thinning of the glomerular basement membrane (GBM) and normal renal function. It is frequent in patients with persistent microscopic hematuria, but cannot be clinically differentiated from the initial stages of Alport syndrome, a severe GBM disorder which progresses to renal failure. We present here linkage of benign familial hematuria with the COL4A3 and COL4A4 genes at 2q35-37 (Zmax = 3.58 at theta = 0.0). Subsequently, a glycine to glutamic acid substitution was identified in the collagenous region of the COL4A4 gene. We conclude that type IV collagen defects cause both benign hematuria and Alport syndrome. Furthermore, our data suggest that BFH patients can be carriers of autosomal recessive Alport syndrome.

Authors

H H Lemmink, W N Nillesen, T Mochizuki, C H Schröder, H G Brunner, B A van Oost, L A Monnens, H J Smeets

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required